The role of genetic factors in predicting results of obesity treatment with sibutramine – serotonin-norepinephrine reuptake inhibitor

The role of genetic factors in predicting results of obesity treatment with sibutramine – serotonin-norepinephrine reuptake inhibitor

Aim. To study the influence of SERT and GNB3 gene polymorphisms on the results of the treatment of obesity by serotonin-norepinephrine reuptake inhibitors.Methods. Patients who didn’t achieve significant weight loss in 3 month period during PrimaVera Study were selected for the genetic evaluation an...

Full description

Bibliographic Details
Main Authors: Marina Galieva, Ekaterina Troshina, Nataliya Mazurina, Andrey Artiushin, Anastasia Pavlova, Anna Volynkina, Marina Aksyonova, Oksana Logvinova
Format: Article
Language:English
Published: Endocrinology Research Centre 2016-12-01
Series:Ожирение и метаболизм
Subjects:
obesity
reduxin
sert
gbn3
polymorphism
Online Access:https://www.omet-endojournals.ru/jour/article/view/8255

Similar Items

Similar Items